Evidence map›Paper›PMID 34455741›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[Unrelated cord blood stem cell transplantation for high-risk/refractory childhood acute myeloid leukemia: a clinical analysis of 160 cases].

E L Chen, H L Liu, L Q Geng, B L Tang, X Y Zhu, W Yao, K D Song, X Wan, G Y Sun, P Qiang and 7 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07588360 (Haploidentical Combined With Cord Blood Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07588360 narecruitingnot on this mapstarted 2025, after this paper: background citation

Haploidentical Combined With Cord Blood Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Prospective, Multicenter Clinical Study

TypeinterventionalSponsorFujian Medical University Union HospitalRan2025 to 2029Enrolled82ConditionsMDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)Armshaplo-cord HSCT, Fludarabine, Cytarabine, Busulfan, Antithymocyte Globulin (ATG), Melphalan, Cyclophosphamide (CTX)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

E L ChenAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
H L LiuAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
L Q GengAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
B L TangAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
X Y ZhuAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
W YaoAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
K D SongAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
X WanAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
G Y SunAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
P QiangAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
Q FanAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
Z W ZhouAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
C C ZhengAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
L ZhangAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
X H ZhangAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
J TongAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
Z M SunAnhui Provincial Hospital Affiliated to University of Science and Technology of China Institute of Hematology, Hefei 230001, China.
Anhui Provincial Hospital · CN

Funding

"HKUST NEW MEDICINE" Joint Fund Innovation Team Project WK9110000001Natural Science Foundation of China 81470350
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cord Blood Stem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteChildHumansRetrospective StudiesAcute myeloid leukemiaChildrenCord blood hematopoietic stem cell transplantation

Identifiers

PMID34455741
PMCPMC8408486
OpenAlexW3196343260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.